Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent	COL2A1 FBN1 FBN2 VWF COMP FN1 MUC17	1.32e-06	188	59	7	GO:0005201
GeneOntologyMolecularFunction	proteoglycan binding	COL2A1 COMP FN1	4.61e-04	51	59	3	GO:0043394
GeneOntologyMolecularFunction	extracellular matrix constituent conferring elasticity	FBN1 FBN2	5.56e-04	12	59	2	GO:0030023
GeneOntologyMolecularFunction	nuclear export signal receptor activity	XPO4 NUP214	5.56e-04	12	59	2	GO:0005049
GeneOntologyMolecularFunction	structural molecule activity conferring elasticity	FBN1 FBN2	7.63e-04	14	59	2	GO:0097493
GeneOntologyMolecularFunction	flippase activity	ABCA3 ATP10D	1.13e-03	17	59	2	GO:0140327
GeneOntologyMolecularFunction	structural molecule activity	COL2A1 FBN1 FBN2 VWF COMP FN1 MUC17 MACF1 NUP214	1.14e-03	891	59	9	GO:0005198
GeneOntologyCellularComponent	collagen-containing extracellular matrix	COL2A1 FBN1 FBN2 VWF ANGPT1 COMP FN1 MUC17 WNT5A	1.65e-05	530	59	9	GO:0062023
GeneOntologyCellularComponent	extracellular matrix	COL2A1 FBN1 FBN2 VWF ANGPT1 COMP FN1 MUC17 WNT5A	8.64e-05	656	59	9	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	COL2A1 FBN1 FBN2 VWF ANGPT1 COMP FN1 MUC17 WNT5A	8.84e-05	658	59	9	GO:0030312
GeneOntologyCellularComponent	microfibril	FBN1 FBN2	5.99e-04	13	59	2	GO:0001527
HumanPheno	Limited elbow extension	COL2A1 FLNA FBN1 FBN2 COMP WNT5A	2.36e-07	60	24	6	HP:0001377
HumanPheno	Limited elbow movement	COL2A1 FLNA FBN1 FBN2 COMP NALCN WNT5A	8.07e-06	168	24	7	HP:0002996
HumanPheno	Avascular necrosis of the capital femoral epiphysis	COL2A1 COMP FN1 WNT5A	9.57e-06	30	24	4	HP:0005743
HumanPheno	Abnormal distal phalanx morphology of finger	COL2A1 FLNA COMP FN1 NALCN WNT5A BCR	1.02e-05	174	24	7	HP:0009832
HumanPheno	Ulnar deviation of the hand or of fingers of the hand	FLNA FBN2 COMP NALCN BCR	1.28e-05	68	24	5	HP:0001193
HumanPheno	Short palm	COL2A1 FLNA FBN1 WNT5A BCR RAI1	1.30e-05	118	24	6	HP:0004279
HumanPheno	Abnormal odontoid process morphology	COL2A1 FLNA COMP FN1	1.60e-05	34	24	4	HP:0003310
HumanPheno	Ovoid vertebral bodies	COL2A1 FBN1 COMP FN1	1.60e-05	34	24	4	HP:0003300
HumanPheno	Spurred humeral metaphysis	COL2A1 FN1	2.13e-05	2	24	2	HP:0003922
HumanPheno	Corner fracture of metaphysis	COL2A1 FN1	2.13e-05	2	24	2	HP:0003908
HumanPheno	Arachnodactyly	COL2A1 FLNA FBN1 FBN2 NALCN BCR	2.59e-05	133	24	6	HP:0001166
HumanPheno	Joint stiffness	COL2A1 FLNA FBN1 FBN2 COMP NALCN RAI1	2.71e-05	202	24	7	HP:0001387
HumanPheno	Juvenile aseptic necrosis	COL2A1 COMP FN1 WNT5A	4.14e-05	43	24	4	HP:0100323
HumanPheno	Abnormal knee physiology	COL2A1 FLNA FBN1 FBN2 COMP	4.26e-05	87	24	5	HP:0034670
HumanPheno	Aplasia/Hypoplasia involving the nose	COL2A1 FLNA FBN1 NALCN WNT5A INTS1 EHMT1 BCR RAI1	4.77e-05	401	24	9	HP:0009924
HumanPheno	Short phalanx of finger	COL2A1 FLNA FBN1 COMP FN1 WNT5A BCR RAI1	4.88e-05	306	24	8	HP:0009803
HumanPheno	Abnormal palm morphology	COL2A1 FLNA FBN1 NALCN COG6 WNT5A EHMT1 BCR RSPO1 RAI1	5.98e-05	521	24	10	HP:0100871
HumanPheno	Increased urinary type 1 collagen N-terminal telopeptide level	COL2A1 FN1	6.36e-05	3	24	2	HP:0032208
HumanPheno	Abnormal upper to lower segment ratio	FBN1 FBN2	6.36e-05	3	24	2	HP:0012772
HumanPheno	Aplasia/Hypoplasia of the phalanges of the hand	COL2A1 FLNA FBN1 COMP FN1 WNT5A BCR RAI1	6.57e-05	319	24	8	HP:0009767
HumanPheno	Slender finger	COL2A1 FLNA FBN1 FBN2 NALCN BCR	7.10e-05	159	24	6	HP:0001238
HumanPheno	Abnormal upper limb metaphysis morphology	COL2A1 COMP FN1	7.16e-05	18	24	3	HP:0009809
HumanPheno	Abnormal hip bone morphology	COL2A1 FLNA FBN1 FBN2 COMP FN1 NALCN COG6 WNT5A MACF1 BCR	7.25e-05	653	24	11	HP:0003272
HumanPheno	Abnormal femoral neck morphology	COL2A1 FLNA COMP FN1 WNT5A BCR	7.36e-05	160	24	6	HP:0003367
HumanPheno	Short nose	COL2A1 FLNA FBN1 NALCN WNT5A INTS1 EHMT1 RAI1	7.51e-05	325	24	8	HP:0003196
HumanPheno	Short finger	COL2A1 FLNA FBN1 COMP FN1 WNT5A BCR RAI1	7.51e-05	325	24	8	HP:0009381
HumanPheno	Malar flattening	COL2A1 FLNA FBN1 WNT5A EHMT1 BCR RAI1	8.20e-05	240	24	7	HP:0000272
HumanPheno	Limitation of joint mobility	COL2A1 FLNA FBN1 FBN2 COMP FN1 NALCN WNT5A RAI1	8.60e-05	432	24	9	HP:0001376
HumanPheno	Long toe	COL2A1 FLNA FBN1 FBN2 NALCN BCR	9.66e-05	168	24	6	HP:0010511
HumanPheno	Abnormal malar bone morphology	COL2A1 FLNA FBN1 WNT5A EHMT1 BCR RAI1	1.04e-04	249	24	7	HP:0012369
HumanPheno	Abnormal zygomatic arch morphology	COL2A1 FLNA FBN1 WNT5A EHMT1 BCR RAI1	1.06e-04	250	24	7	HP:0005557
HumanPheno	Abnormal zygomatic bone morphology	COL2A1 FLNA FBN1 WNT5A EHMT1 BCR RAI1	1.06e-04	250	24	7	HP:0010668
HumanPheno	Flat face	COL2A1 FLNA FN1 WNT5A EHMT1	1.10e-04	106	24	5	HP:0012368
HumanPheno	Flexion contracture of finger	COL2A1 FLNA FBN1 FBN2 NALCN WNT5A BCR	1.27e-04	257	24	7	HP:0012785
HumanPheno	Abnormality of the calcaneus	COL2A1 FLNA FBN1 NALCN	1.27e-04	57	24	4	HP:0008364
HumanPheno	Hyperconvex vertebral body endplates	COL2A1 FN1	1.27e-04	4	24	2	HP:0004603
HumanPheno	Anisospondyly	COL2A1 FLNA	1.27e-04	4	24	2	HP:0002879
HumanPheno	Finger joint contracture	COL2A1 FLNA FBN1 FBN2 NALCN WNT5A BCR	1.33e-04	259	24	7	HP:0034681
HumanPheno	Pectus carinatum	COL2A1 FBN1 FBN2 FN1 NALCN WNT5A	1.33e-04	178	24	6	HP:0000768
HumanPheno	Abnormal phalangeal joint morphology of the hand	COL2A1 FLNA FBN1 FBN2 NALCN WNT5A BCR	1.43e-04	262	24	7	HP:0006261
HumanPheno	Aplasia/Hypoplasia of fingers	COL2A1 FLNA FBN1 COMP FN1 WNT5A BCR RAI1	1.74e-04	366	24	8	HP:0006265
HumanPheno	Abnormal sternum morphology	COL2A1 FLNA FBN1 FBN2 FN1 NALCN WNT5A INTS1 EHMT1	1.77e-04	474	24	9	HP:0000766
HumanPheno	Short distal phalanx of finger	COL2A1 FLNA COMP FN1 BCR	1.90e-04	119	24	5	HP:0009882
HumanPheno	Abnormal pelvic girdle bone morphology	COL2A1 FLNA FBN1 FBN2 COMP FN1 NALCN COG6 WNT5A MACF1 BCR	2.04e-04	730	24	11	HP:0002644
HumanPheno	Biconvex vertebral bodies	COL2A1 FN1	2.11e-04	5	24	2	HP:0004625
HumanPheno	Elevated urinary collagen degradation products	COL2A1 FN1	2.11e-04	5	24	2	HP:0033384
HumanPheno	Mitral valve prolapse	COL2A1 FLNA FBN1 FBN2 VWF	2.23e-04	123	24	5	HP:0001634
HumanPheno	Abnormal cheek morphology	COL2A1 FLNA FBN1 FN1 NALCN INTS1 BCR	2.26e-04	282	24	7	HP:0004426
HumanPheno	Abnormality of the elbow	COL2A1 FLNA FBN1 FBN2 COMP NALCN WNT5A	2.26e-04	282	24	7	HP:0009811
HumanPheno	Abnormal hip joint morphology	COL2A1 FLNA FBN1 FBN2 COMP NALCN COG6 WNT5A MACF1	2.29e-04	490	24	9	HP:0001384
HumanPheno	Aplasia/Hypoplasia of the distal phalanges of the hand	COL2A1 FLNA COMP FN1 BCR	2.31e-04	124	24	5	HP:0009835
HumanPheno	Hypoplasia of the odontoid process	COL2A1 COMP FN1	2.50e-04	27	24	3	HP:0003311
HumanPheno	Persistence of primary teeth	FLNA WNT5A EHMT1	2.50e-04	27	24	3	HP:0006335
HumanPheno	Coxa vara	COL2A1 COMP FN1 WNT5A	2.52e-04	68	24	4	HP:0002812
HumanPheno	Abnormality of the humerus	COL2A1 FLNA COMP FN1	2.52e-04	68	24	4	HP:0003063
HumanPheno	Abnormal femoral neck/head morphology	COL2A1 FLNA COMP FN1 WNT5A BCR	2.60e-04	201	24	6	HP:0003366
HumanPheno	Abnormal aortic valve morphology	FLNA FBN1 FBN2 VWF EHMT1 BCR RAI1	2.64e-04	289	24	7	HP:0001646
HumanPheno	Abnormal synovial membrane morphology	COL2A1 FLNA FBN1 FBN2 COMP NALCN COG6 WNT5A MACF1	2.80e-04	503	24	9	HP:0005262
HumanPheno	Joint contracture of the hand	COL2A1 FLNA FBN1 FBN2 NALCN WNT5A BCR	3.06e-04	296	24	7	HP:0009473
HumanPheno	Crumpled ear	FBN1 FBN2	3.15e-04	6	24	2	HP:0009901
HumanPheno	Abnormal humeral metaphysis morphology	COL2A1 FN1	3.15e-04	6	24	2	HP:0003907
HumanPheno	Abnormal femur morphology	COL2A1 FLNA FBN1 COMP FN1 WNT5A BCR	3.60e-04	304	24	7	HP:0002823
HumanPheno	Long fingers	COL2A1 FLNA FBN1 FBN2 NALCN EHMT1 BCR	3.75e-04	306	24	7	HP:0100807
HumanPheno	Abnormality of the chin	COL2A1 FLNA FBN1 FN1 NALCN EHMT1 BCR RAI1	3.76e-04	409	24	8	HP:0000306
HumanPheno	Abnormal limb epiphysis morphology	COL2A1 FLNA COMP FN1 WNT5A	3.81e-04	138	24	5	HP:0006505
HumanPheno	Protruding ear	COL2A1 FLNA FBN1 FN1 NALCN INTS1	4.14e-04	219	24	6	HP:0000411
HumanPheno	Aplasia/Hypoplasia of the phalanges of the 5th finger	COL2A1 WNT5A RAI1	4.17e-04	32	24	3	HP:0009376
HumanPheno	Inguinal hernia	COL2A1 FLNA FBN1 NALCN WNT5A EHMT1 BCR	4.23e-04	312	24	7	HP:0000023
HumanPheno	Limited hip movement	COL2A1 FBN2 COMP NALCN	4.28e-04	78	24	4	HP:0008800
HumanPheno	Underfolded helix	COL2A1 FN1	4.40e-04	7	24	2	HP:0008577
HumanPheno	Lens luxation	COL2A1 FBN1	4.40e-04	7	24	2	HP:0012019
HumanPheno	Irregular acetabular roof	COL2A1 COMP	4.40e-04	7	24	2	HP:0008833
HumanPheno	Bowing of the long bones	COL2A1 FLNA FBN1 FBN2 COMP FN1 BCR	4.57e-04	316	24	7	HP:0006487
HumanPheno	Aplasia/hypoplasia involving bones of the hand	COL2A1 FLNA FBN1 COMP FN1 NALCN WNT5A BCR RAI1	4.65e-04	538	24	9	HP:0005927
HumanPheno	Abnormal mitral valve morphology	COL2A1 FLNA FBN1 FBN2 VWF	4.94e-04	146	24	5	HP:0031477
HumanPheno	Abnormality of the upper arm	COL2A1 FLNA COMP FN1	4.95e-04	81	24	4	HP:0001454
HumanPheno	Anomaly of the limb diaphyses	COL2A1 FLNA FBN1 FBN2 COMP FN1 BCR	5.12e-04	322	24	7	HP:0006504
HumanPheno	Abnormality of the thigh	COL2A1 FLNA FBN1 COMP FN1 WNT5A BCR	5.12e-04	322	24	7	HP:0001439
HumanPheno	Abnormality of primary teeth	FLNA WNT5A EHMT1 RAI1	5.19e-04	82	24	4	HP:0006481
HumanPheno	Cone-shaped epiphysis	COL2A1 FLNA FBN1 COMP	5.19e-04	82	24	4	HP:0010579
HumanPheno	Pectus excavatum	COL2A1 FLNA FBN1 FBN2 WNT5A INTS1 EHMT1	5.22e-04	323	24	7	HP:0000767
HumanPheno	Brachydactyly (hand)	COL2A1 FLNA FBN1 COMP FN1 WNT5A BCR RAI1	5.29e-04	430	24	8	HP:0100667
HumanPheno	Facial asymmetry	COL2A1 FLNA FN1 MACF1 BCR	5.43e-04	149	24	5	HP:0000324
HumanPheno	Abnormality of the epiphysis of the femoral head	COL2A1 COMP FN1 WNT5A	5.43e-04	83	24	4	HP:0010574
HumanPheno	Limitation of knee mobility	COL2A1 FLNA FBN2	5.45e-04	35	24	3	HP:0010501
HumanPheno	Elbow dislocation	FLNA FBN1 FBN2 WNT5A	5.69e-04	84	24	4	HP:0003042
HumanPheno	Hypoplastic facial bones	COL2A1 FLNA FBN1 WNT5A EHMT1 BCR RAI1	6.06e-04	331	24	7	HP:0002692
HumanPheno	Abnormality of the cervical spine	COL2A1 FLNA FBN2 COMP FN1 NALCN WNT5A INTS1	6.08e-04	439	24	8	HP:0003319
HumanPheno	Aplasia/Hypoplasia of facial bones	COL2A1 FLNA FBN1 WNT5A EHMT1 BCR RAI1	6.17e-04	332	24	7	HP:0034261
HumanPheno	Abnormal femoral epiphysis morphology	COL2A1 COMP FN1 WNT5A	6.22e-04	86	24	4	HP:0006499
HumanPheno	Ulnar deviation of finger	FBN2 NALCN BCR	6.43e-04	37	24	3	HP:0009465
HumanPheno	Abnormal forearm morphology	COL2A1 FLNA COMP NALCN WNT5A RAI1	6.60e-04	239	24	6	HP:0002973
HumanPheno	Flexion contracture of finger	FLNA FBN1 FBN2 NALCN WNT5A BCR	6.75e-04	240	24	6	HP:0005651
HumanPheno	Camptodactyly (hands)	FLNA FBN1 FBN2 NALCN WNT5A BCR	6.75e-04	240	24	6	HP:0010563
HumanPheno	Joint contractures involving the joints of the feet	FLNA FBN1 FBN2 NALCN WNT5A BCR	6.75e-04	240	24	6	HP:0100492
HumanPheno	Camptodactyly of finger	FLNA FBN1 FBN2 NALCN WNT5A BCR	6.75e-04	240	24	6	HP:0100490
HumanPheno	Interphalangeal joint contracture of finger	FLNA FBN1 FBN2 NALCN WNT5A BCR	6.75e-04	240	24	6	HP:0001220
HumanPheno	Camptodactyly of toe	FLNA FBN1 FBN2 NALCN WNT5A BCR	6.75e-04	240	24	6	HP:0001836
HumanPheno	Flexion contracture of toe	FLNA FBN1 FBN2 NALCN WNT5A BCR	6.75e-04	240	24	6	HP:0005830
HumanPheno	Toe joint contracture	FLNA FBN1 FBN2 NALCN WNT5A BCR	6.90e-04	241	24	6	HP:0034675
MousePheno	hemorrhage	COL2A1 WDR91 FLNA ABCA3 FBN1 VWF FN1 NALCN COG6 F2R	4.71e-05	664	46	10	MP:0001914
MousePheno	abnormal phalanx morphology	COL2A1 FBN1 FBN2 RAI1	1.11e-04	76	46	4	MP:0005306
MousePheno	abnormal radius morphology	COL2A1 FBN1 FBN2 WNT5A	1.49e-04	82	46	4	MP:0000552
MousePheno	abnormal ulna morphology	COL2A1 FBN1 FBN2 WNT5A	1.63e-04	84	46	4	MP:0005108
MousePheno	abnormal pelvic girdle bone morphology	COL2A1 FBN1 FBN2 COMP	1.87e-04	87	46	4	MP:0004509
MousePheno	increased chondrocyte apoptosis	COL2A1 COMP	2.20e-04	7	46	2	MP:0014103
MousePheno	abnormal paired-pulse ratio	BTBD9 RYR2	2.20e-04	7	46	2	MP:0014252
MousePheno	internal hemorrhage	COL2A1 WDR91 ABCA3 FBN1 VWF COG6 F2R	2.49e-04	387	46	7	MP:0001634
MousePheno	abnormal response to cardiac infarction	VWF F2R RYR2 LIMS2	2.52e-04	94	46	4	MP:0000343
MousePheno	abnormal chest morphology	COL2A1 FBN1 WNT5A	2.80e-04	39	46	3	MP:0004134
MousePheno	abnormal joint morphology	COL2A1 FBN2 COMP COG6 WNT5A EHMT1 RAI1	2.91e-04	397	46	7	MP:0002932
MousePheno	abnormal chondrocyte apoptosis	COL2A1 COMP	2.93e-04	8	46	2	MP:0014102
MousePheno	short radius	COL2A1 FBN1 WNT5A	3.03e-04	40	46	3	MP:0004355
MousePheno	decreased radius size	COL2A1 FBN1 WNT5A	3.03e-04	40	46	3	MP:0030886
MousePheno	abnormal blood circulation	COL2A1 WDR91 FLNA ABCA3 FBN1 VWF FN1 NALCN COG6 F2R	3.44e-04	845	46	10	MP:0002128
MousePheno	abnormal forelimb zeugopod morphology	COL2A1 FBN1 FBN2 WNT5A	3.45e-04	102	46	4	MP:0003855
MousePheno	short ulna	COL2A1 FBN1 WNT5A	4.58e-04	46	46	3	MP:0004359
MousePheno	decreased ulna size	COL2A1 FBN1 WNT5A	4.58e-04	46	46	3	MP:0030900
MousePheno	abnormal limb long bone morphology	COL2A1 FOXD2 FBN1 FBN2 COMP WNT5A F2R RAI1	4.71e-04	568	46	8	MP:0011504
Domain	FBN	FBN1 FBN2	2.74e-05	3	57	2	IPR011398
Domain	Growth_fac_rcpt_	ATRN FBN1 FBN2 COMP RSPO1	1.12e-04	156	57	5	IPR009030
Domain	EGF_1	ATRN FBN1 FBN2 COMP FN1 MUC17	1.24e-04	255	57	6	PS00022
Domain	Fer2	FDX1 NDUFS1	1.36e-04	6	57	2	PF00111
Domain	2FE2S_FER_2	FDX1 NDUFS1	1.36e-04	6	57	2	PS51085
Domain	2Fe-2S_ferredoxin-type	FDX1 NDUFS1	1.36e-04	6	57	2	IPR001041
Domain	EGF-like_CS	ATRN FBN1 FBN2 COMP FN1 MUC17	1.40e-04	261	57	6	IPR013032
Domain	TB	FBN1 FBN2	1.90e-04	7	57	2	PF00683
Domain	-	FBN1 FBN2	2.53e-04	8	57	2	3.90.290.10
Domain	TB	FBN1 FBN2	3.25e-04	9	57	2	PS51364
Domain	TB_dom	FBN1 FBN2	3.25e-04	9	57	2	IPR017878
Domain	EGF_3	ATRN FBN1 FBN2 COMP MUC17	7.43e-04	235	57	5	PS50026
Domain	EGF	ATRN FBN1 FBN2 COMP MUC17	7.43e-04	235	57	5	SM00181
Domain	Beta-grasp_dom	FDX1 NDUFS1	8.13e-04	14	57	2	IPR012675
Domain	-	FDX1 NDUFS1	8.13e-04	14	57	2	3.10.20.30
Domain	EGF-like_dom	ATRN FBN1 FBN2 COMP MUC17	9.63e-04	249	57	5	IPR000742
Domain	CH	FLNA MACF1 CNN2	1.03e-03	65	57	3	SM00033
Domain	DUF1605	DHX38 DHX32	1.21e-03	17	57	2	IPR011709
Domain	OB_NTP_bind	DHX38 DHX32	1.21e-03	17	57	2	PF07717
Domain	EGF_2	ATRN FBN1 FBN2 COMP MUC17	1.27e-03	265	57	5	PS01186
Domain	CH	FLNA MACF1 CNN2	1.28e-03	70	57	3	PF00307
Domain	-	FLNA MACF1 CNN2	1.33e-03	71	57	3	1.10.418.10
Domain	HA2	DHX38 DHX32	1.36e-03	18	57	2	SM00847
Domain	HA2	DHX38 DHX32	1.36e-03	18	57	2	PF04408
Domain	Helicase-assoc_dom	DHX38 DHX32	1.36e-03	18	57	2	IPR007502
Domain	CH	FLNA MACF1 CNN2	1.44e-03	73	57	3	PS50021
Domain	CH-domain	FLNA MACF1 CNN2	1.56e-03	75	57	3	IPR001715
Domain	Actinin_actin-bd_CS	FLNA MACF1	2.22e-03	23	57	2	IPR001589
Domain	ACTININ_2	FLNA MACF1	2.22e-03	23	57	2	PS00020
Domain	ACTININ_1	FLNA MACF1	2.22e-03	23	57	2	PS00019
Domain	EGF_CA	FBN1 FBN2 COMP	2.31e-03	86	57	3	PF07645
Domain	cEGF	FBN1 FBN2	2.84e-03	26	57	2	IPR026823
Domain	cEGF	FBN1 FBN2	2.84e-03	26	57	2	PF12662
Domain	EGF_Ca-bd_CS	FBN1 FBN2 COMP	3.24e-03	97	57	3	IPR018097
Domain	VWC	COL2A1 VWF	3.29e-03	28	57	2	PF00093
Domain	EGF_CA	FBN1 FBN2 COMP	3.44e-03	99	57	3	PS01187
Domain	VWFC_1	COL2A1 VWF	5.39e-03	36	57	2	PS01208
Domain	VWC	COL2A1 VWF	6.00e-03	38	57	2	SM00214
Domain	VWFC_2	COL2A1 VWF	6.00e-03	38	57	2	PS50184
Pathway	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	COL2A1 FBN1 VWF COMP FN1	6.99e-06	76	50	5	MM14867
Pathway	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	COL2A1 FBN1 VWF COMP FN1	1.21e-05	85	50	5	M16441
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING	COL2A1 VWF ANGPT1 COMP FN1 CREB3L3 F2R	8.76e-05	302	50	7	M39719
Pathway	WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE	FLNA FBN1 FBN2	9.14e-05	25	50	3	M39713
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY	COL2A1 VWF ANGPT1 COMP FN1 CREB3L3 F2R	1.41e-04	326	50	7	MM15917
Pathway	WP_PI3KAKT_SIGNALING	COL2A1 VWF ANGPT1 COMP FN1 CREB3L3 F2R	1.79e-04	339	50	7	M39736
Pathway	REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES	FBN1 FBN2 FN1	1.94e-04	32	50	3	MM14854
Pathway	KEGG_ECM_RECEPTOR_INTERACTION	COL2A1 VWF COMP FN1	2.19e-04	84	50	4	M7098
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	COL2A1 FBN1 FBN2 VWF COMP FN1	2.87e-04	258	50	6	MM14572
Pathway	REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES	FBN1 FBN2 FN1	3.00e-04	37	50	3	M27134
Pathway	REACTOME_ELASTIC_FIBRE_FORMATION	FBN1 FBN2 FN1	3.51e-04	39	50	3	MM14601
Pathway	REACTOME_ELASTIC_FIBRE_FORMATION	FBN1 FBN2 FN1	5.02e-04	44	50	3	M26969
Pathway	REACTOME_ECM_PROTEOGLYCANS	COL2A1 COMP FN1	6.10e-04	47	50	3	MM14925
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	COL2A1 FBN1 FBN2 VWF COMP FN1	6.39e-04	300	50	6	M610
Pathway	WP_FOCAL_ADHESION	COL2A1 FLNA VWF COMP FN1	6.74e-04	199	50	5	M39402
Pathway	KEGG_FOCAL_ADHESION	COL2A1 FLNA VWF COMP FN1	6.74e-04	199	50	5	M7253
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	COL2A1 FBN1 FBN2 FN1	7.01e-04	114	50	4	MM14571
Pathway	REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING	FLNA VWF	7.95e-04	12	50	2	MM15093
Pathway	REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING	FLNA VWF	7.95e-04	12	50	2	M27352
Pathway	REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	VWF FN1	1.26e-03	15	50	2	M12101
Pathway	REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	VWF FN1	1.26e-03	15	50	2	M1262
Pathway	REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	VWF FN1	1.26e-03	15	50	2	MM14959
Pathway	REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	VWF FN1	1.26e-03	15	50	2	MM14961
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	COL2A1 FBN1 FBN2 FN1	1.51e-03	140	50	4	M587
Pathway	PID_INTEGRIN5_PATHWAY	FBN1 FN1	1.62e-03	17	50	2	M212
Pathway	PID_INTEGRIN1_PATHWAY	COL2A1 FBN1 FN1	1.64e-03	66	50	3	M18
Pathway	WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY	COL2A1 FN1	1.82e-03	18	50	2	M39586
Pathway	REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS	FLNA LIMS2	1.82e-03	18	50	2	MM15123
Pathway	REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS	FLNA LIMS2	1.82e-03	18	50	2	M840
Pubmed	Limb- and tendon-specific Adamtsl2 deletion identifies a role for ADAMTSL2 in tendon growth in a mouse model for geleophysic dysplasia.	COL2A1 FBN1 FBN2 FN1	1.67e-09	10	60	4	30738849
Pubmed	Lubricin binds cartilage proteins, cartilage oligomeric matrix protein, fibronectin and collagen II at the cartilage surface.	COL2A1 COMP FN1	4.88e-09	3	60	3	29030641
Pubmed	Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly.	FBN1 FBN2 FN1	1.95e-08	4	60	3	25034023
Pubmed	Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease.	COL2A1 ABCA3 FBN1 FBN2 FN1	3.15e-08	52	60	5	30389913
Pubmed	Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis.	FBN1 FBN2 FN1	2.72e-07	8	60	3	23055981
Pubmed	Adamts17 is involved in skeletogenesis through modulation of BMP-Smad1/5/8 pathway.	COL2A1 FBN1 FBN2	2.72e-07	8	60	3	31201465
Pubmed	Comprehensive proteomic characterization of stem cell-derived extracellular matrices.	COL2A1 FBN1 FBN2 FN1 WNT5A	4.03e-07	86	60	5	28327460
Pubmed	Microfibril-associated glycoprotein-2 interacts with fibrillin-1 and fibrillin-2 suggesting a role for MAGP-2 in elastic fiber assembly.	FBN1 FBN2 VWF	4.07e-07	9	60	3	12122015
Pubmed	Mice lacking the extracellular matrix adaptor protein matrilin-2 develop without obvious abnormalities.	COL2A1 FBN2 FN1	4.07e-07	9	60	3	15296947
Pubmed	Poglut2/3 double knockout in mice results in neonatal lethality with reduced levels of fibrillin in lung tissues.	FBN1 FBN2 FN1	4.07e-07	9	60	3	38844137
Pubmed	Fibrillin-2 is a key mediator of smooth muscle extracellular matrix homeostasis during mouse tracheal tubulogenesis.	COL2A1 FBN1 FBN2 FN1	6.98e-07	40	60	4	30578393
Pubmed	Disruption of murine Adamtsl4 results in zonular fiber detachment from the lens and in retinal pigment epithelium dedifferentiation.	FBN1 FBN2 FN1	1.06e-06	12	60	3	26405179
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	FLNA FN1 PELP1 DHX38 INTS1 MACF1 NUP214 NDUFS1 RAI1	1.73e-06	653	60	9	22586326
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	COL2A1 FBN1 FBN2 FN1	1.74e-06	50	60	4	23658023
Pubmed	Homo- and heterotypic fibrillin-1 and -2 interactions constitute the basis for the assembly of microfibrils.	FBN1 FBN2	2.93e-06	2	60	2	12399449
Pubmed	Fibrillin-1 and fibrillin-2 are essential for formation of thick oxytalan fibers in human nonpigmented ciliary epithelial cells in vitro.	FBN1 FBN2	2.93e-06	2	60	2	21851253
Pubmed	Fibrillins can co-assemble in fibrils, but fibrillin fibril composition displays cell-specific differences.	FBN1 FBN2	2.93e-06	2	60	2	12429739
Pubmed	Fibrillin assembly requires fibronectin.	FBN1 FN1	2.93e-06	2	60	2	19037100
Pubmed	New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis.	FBN1 FBN2	2.93e-06	2	60	2	30044367
Pubmed	Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils.	FBN1 FBN2	2.93e-06	2	60	2	21440062
Pubmed	MAGP-2 has multiple binding regions on fibrillins and has covalent periodic association with fibrillin-containing microfibrils.	FBN1 FBN2	2.93e-06	2	60	2	15131124
Pubmed	Double heterozygosity for pseudoachondroplasia and spondyloepiphyseal dysplasia congenita.	COL2A1 COMP	2.93e-06	2	60	2	11746045
Pubmed	Differences in susceptibility of inbred and outbred infant mice to enterotoxigenic Escherichia coli of bovine, porcine and human origin.	FBN2 FN1	2.93e-06	2	60	2	2179554
Pubmed	Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development.	FBN1 FBN2	2.93e-06	2	60	2	12524050
Pubmed	Microfibril structure masks fibrillin-2 in postnatal tissues.	FBN1 FBN2	2.93e-06	2	60	2	20404337
Pubmed	A comprehensive genetic linkage map of the human genome. NIH/CEPH Collaborative Mapping Group.	COL2A1 VWF	2.93e-06	2	60	2	1439770
Pubmed	Fibrillln mutations in Marfan syndrome and related phenotypes.	FBN1 FBN2	2.93e-06	2	60	2	8791520
Pubmed	Three-dimensional visualization of extracellular matrix networks during murine development.	FBN2 FN1	2.93e-06	2	60	2	29352963
Pubmed	Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices.	FBN1 FBN2	2.93e-06	2	60	2	8120105
Pubmed	The fibrillinopathies: New insights with focus on the paradigm of opposing phenotypes for both FBN1 and FBN2.	FBN1 FBN2	2.93e-06	2	60	2	35419902
Pubmed	Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18.	FBN1 FBN2	2.93e-06	2	60	2	8307578
Pubmed	Fibrillin assembly: dimer formation mediated by amino-terminal sequences.	FBN1 FBN2	2.93e-06	2	60	2	10504303
Pubmed	Decreased Plasma COMP and Increased Plasma CTX-II Levels in a Chinese Pseudoachondroplasia Family with Novel COMP Mutation.	COL2A1 COMP	2.93e-06	2	60	2	29104872
Pubmed	Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils.	FBN1 FBN2	2.93e-06	2	60	2	7744963
Pubmed	Selective integrin subunit reduction disrupts fibronectin extracellular matrix deposition and fibrillin 1 gene expression.	FBN1 FN1	2.93e-06	2	60	2	22782528
Pubmed	Fibrillin microfibrils in bone physiology.	FBN1 FBN2	2.93e-06	2	60	2	26408953
Pubmed	Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin.	COMP FN1	2.93e-06	2	60	2	12225811
Pubmed	A second fibronectin-binding region is present in collagen alpha chains.	COL2A1 FN1	2.93e-06	2	60	2	2229073
Pubmed	Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration.	FBN1 FBN2	2.93e-06	2	60	2	18006876
Pubmed	Targeting ovarian tumor cell adhesion mediated by tissue transglutaminase.	FN1 BCR	2.93e-06	2	60	2	21330459
Pubmed	Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis.	FBN1 FBN2	2.93e-06	2	60	2	24833718
Pubmed	Wnt5A activates the calpain-mediated cleavage of filamin A.	FLNA WNT5A	2.93e-06	2	60	2	19177143
Pubmed	Fibrillin-1 microfibril deposition is dependent on fibronectin assembly.	FBN1 FN1	2.93e-06	2	60	2	18653538
Pubmed	Nonselective assembly of fibrillin 1 and fibrillin 2 in the rodent ocular zonule and in cultured cells: implications for Marfan syndrome.	FBN1 FBN2	2.93e-06	2	60	2	24265020
Pubmed	Spondylometaphyseal Dysplasia, Corner Fracture Type	COL2A1 FN1	2.93e-06	2	60	2	32200603
Pubmed	Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen.	COL2A1 COMP	2.93e-06	2	60	2	9685393
Pubmed	In vivo studies of mutant fibrillin-1 microfibrils.	FBN1 FBN2	2.93e-06	2	60	2	20529844
Pubmed	Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development.	FBN1 FBN2	2.93e-06	2	60	2	25524144
Pubmed	Definition of the native and denatured type II collagen binding site for fibronectin using a recombinant collagen system.	COL2A1 FN1	2.93e-06	2	60	2	24375478
Pubmed	Fibrillin-1 mutations causing Weill-Marchesani syndrome and acromicric and geleophysic dysplasias disrupt heparan sulfate interactions.	FBN1 FBN2	2.93e-06	2	60	2	23133647
Pubmed	Fibrillins 1 and 2 perform partially overlapping functions during aortic development.	FBN1 FBN2	2.93e-06	2	60	2	16407178
Pubmed	Complex contributions of fibronectin to initiation and maturation of microfibrils.	FBN1 FN1	2.93e-06	2	60	2	24070235
Pubmed	Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes.	FBN1 FBN2	2.93e-06	2	60	2	1852206
Pubmed	Biochemical markers in the diagnosis of chondral defects following anterior cruciate ligament insufficiency.	COL2A1 COMP	2.93e-06	2	60	2	21221577
Pubmed	N-terminal domains of fibrillin 1 and fibrillin 2 direct the formation of homodimers: a possible first step in microfibril assembly.	FBN1 FBN2	2.93e-06	2	60	2	10359653
Pubmed	Plasma fibronectin supports hemostasis and regulates thrombosis.	VWF FN1	2.93e-06	2	60	2	25180602
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	COL2A1 FBN1 FBN2 VWF FN1	3.76e-06	135	60	5	28675934
Pubmed	Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development.	FBN1 FBN2 FN1	3.91e-06	18	60	3	35503090
Pubmed	Fibronectin isoforms promote postnatal skeletal development.	COL2A1 FBN1 FN1	3.91e-06	18	60	3	39159790
Pubmed	ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells.	FBN1 FBN2 FN1	3.91e-06	18	60	3	39040056
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	COL2A1 FBN1 VWF COMP FN1	5.52e-06	146	60	5	27068509
Pubmed	Functional proteomics mapping of a human signaling pathway.	FLNA FBN2 VWF FN1 PELP1 MACF1 RYR2 LIMS2	7.80e-06	591	60	8	15231748
Pubmed	Msx genes define a population of mural cell precursors required for head blood vessel maturation.	VWF ANGPT1 FN1	8.43e-06	23	60	3	21693521
Pubmed	Interaction of tropoelastin with the amino-terminal domains of fibrillin-1 and fibrillin-2 suggests a role for the fibrillins in elastic fiber assembly.	FBN1 FBN2	8.77e-06	3	60	2	10825173
Pubmed	Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases.	NUP214 BCR	8.77e-06	3	60	2	18784740
Pubmed	Adamts10 inactivation in mice leads to persistence of ocular microfibrils subsequent to reduced fibrillin-2 cleavage.	FBN1 FBN2	8.77e-06	3	60	2	30201140
Pubmed	The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells.	ANGPT1 F2R	8.77e-06	3	60	2	16803467
Pubmed	Chondrogenic differentiation of induced pluripotent stem cells from osteoarthritic chondrocytes in alginate matrix.	COL2A1 COMP	8.77e-06	3	60	2	22241609
Pubmed	Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development.	VWF FN1	8.77e-06	3	60	2	10625534
Pubmed	Platelets, inflammatory cells, von Willebrand factor, syndecan-1, fibrin, fibronectin, and bacteria co-localize in the liver thrombi of Bacillus anthracis-infected mice.	VWF FN1	8.77e-06	3	60	2	22001909
Pubmed	Dual Targeting of Angipoietin-1 and von Willebrand Factor by microRNA-671-5p Attenuates Liver Angiogenesis and Fibrosis.	VWF ANGPT1	8.77e-06	3	60	2	35014213
Pubmed	Comparative analysis with collagen type II distinguishes cartilage oligomeric matrix protein as a primary TGFβ-responsive gene.	COL2A1 COMP	8.77e-06	3	60	2	21843649
Pubmed	Vascular development in the mouse embryonic pancreas and lung.	VWF ANGPT1	8.77e-06	3	60	2	10359181
Pubmed	PR3 and elastase alter PAR1 signaling and trigger vWF release via a calcium-independent mechanism from glomerular endothelial cells.	VWF F2R	8.77e-06	3	60	2	22952809
Pubmed	Mice lacking the extracellular matrix protein MAGP1 display delayed thrombotic occlusion following vessel injury.	VWF FN1	8.77e-06	3	60	2	18281502
Pubmed	Molecular structure and interaction of recombinant human type XVI collagen.	FBN1 FN1	8.77e-06	3	60	2	15165854
Pubmed	The Angiopoietin-1 Variant COMP-Ang1 Enhances BMP2-Induced Bone Regeneration with Recruiting Pericytes in Critical Sized Calvarial Defects.	ANGPT1 COMP	8.77e-06	3	60	2	26465321
Pubmed	Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation.	FBN1 FBN2	8.77e-06	3	60	2	20855508
Pubmed	Adamts18 modulates the development of the aortic arch and common carotid artery.	FBN1 FBN2 FN1	1.23e-05	26	60	3	34189436
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	COL2A1 FBN1 FBN2 VWF FN1	1.33e-05	175	60	5	28071719
Pubmed	Laser capture microdissection and cDNA array analysis for identification of mouse KIAA/FLJ genes differentially expressed in the embryonic dorsal spinal cord.	MACF1 NUP214 BCR	1.39e-05	27	60	3	19026994
Pubmed	Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein.	FBN1 FBN2	1.75e-05	4	60	2	12429738
Pubmed	Human eye development is characterized by coordinated expression of fibrillin isoforms.	FBN1 FBN2	1.75e-05	4	60	2	25406291
Pubmed	Immunolocalization of microfibril and microfibril-associated proteins in the subendothelial matrix of the developing mouse aorta.	FBN1 FN1	1.75e-05	4	60	2	8006086
Pubmed	Extracellular microfibrils control osteoblast-supported osteoclastogenesis by restricting TGF{beta} stimulation of RANKL production.	FBN1 FBN2	1.75e-05	4	60	2	20729550
Pubmed	Comprehensive genetic analysis of relevant four genes in 49 patients with Marfan syndrome or Marfan-related phenotypes.	FBN1 FBN2	1.75e-05	4	60	2	16835936
Pubmed	Sex and ethnic differences in the association of ASPN, CALM1, COL2A1, COMP, and FRZB with genetic susceptibility to osteoarthritis of the knee.	COL2A1 COMP	1.75e-05	4	60	2	17195216
Pubmed	Serum levels of TNF-α, IL-1β, COMP, and CTX-II in patients with Kashin-Beck disease in Sichuan, China.	COL2A1 COMP	1.75e-05	4	60	2	22068351
Pubmed	Heritable Thoracic Aortic Disease Overview	FLNA FBN1 FBN2	1.92e-05	30	60	3	20301299
Pubmed	TBX1 is required for normal stria vascularis and semicircular canal development.	ATRN FBN1 COMP	2.12e-05	31	60	3	31550482
Pubmed	Adamtsl2 deletion results in bronchial fibrillin microfibril accumulation and bronchial epithelial dysplasia--a novel mouse model providing insights into geleophysic dysplasia.	FBN1 FBN2 FN1	2.12e-05	31	60	3	25762570
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KNTC1 RIMKLB ANGPT1 DHX38 WSCD2 MACF1 BTBD9	2.22e-05	493	60	7	15368895
Pubmed	Characterization of Microfibrillar-associated Protein 4 (MFAP4) as a Tropoelastin- and Fibrillin-binding Protein Involved in Elastic Fiber Formation.	FBN1 FBN2	2.92e-05	5	60	2	26601954
Pubmed	Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A.	FLNA WNT5A	2.92e-05	5	60	2	18667433
Pubmed	Relaxin regulates fibrillin 2, but not fibrillin 1, mRNA and protein expression by human dermal fibroblasts and murine fetal skin.	FBN1 FBN2	2.92e-05	5	60	2	12590922
Pubmed	Thrombin down-regulates the TGF-beta-mediated synthesis of collagen and fibronectin by human proximal tubule epithelial cells through the EPCR-dependent activation of PAR-1.	FN1 F2R	2.92e-05	5	60	2	20506163
Pubmed	Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse.	VWF FN1	2.92e-05	5	60	2	11891199
Pubmed	Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor.	VWF FN1	2.92e-05	5	60	2	15799029
Pubmed	Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor.	VWF FN1	2.92e-05	5	60	2	19036705
Pubmed	Fibrillin-1 interactions with fibulins depend on the first hybrid domain and provide an adaptor function to tropoelastin.	FBN1 FBN2	2.92e-05	5	60	2	17255108
Interaction	COL9A1 interactions	COL2A1 COMP FN1	5.70e-06	13	56	3	int:COL9A1
Interaction	COMP interactions	COL2A1 COMP FN1	2.24e-05	20	56	3	int:COMP
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	TIMM13 COMP GATAD2A CREB3L3 ZNF844 CNN2 ELL	8.04e-05	797	60	7	chr19p13
GeneFamily	DEAH-box helicases	DHX38 DHX32	5.90e-04	16	41	2	500
GeneFamily	Endogenous ligands	VWF FN1 WNT5A RSPO1	1.99e-03	237	41	4	542
Coexpression	NABA_CORE_MATRISOME	COL2A1 FBN1 FBN2 VWF COMP FN1 RSPO1	2.19e-06	270	58	7	MM17057
Coexpression	NABA_CORE_MATRISOME	COL2A1 FBN1 FBN2 VWF COMP FN1 RSPO1	2.47e-06	275	58	7	M5884
Coexpression	CHICAS_RB1_TARGETS_CONFLUENT	USP44 FLNA FBN1 FBN2 FN1 NALCN AK5 CNN2 LIMS2	4.04e-06	567	58	9	M2129
Coexpression	NABA_ECM_GLYCOPROTEINS	FBN1 FBN2 VWF COMP FN1 RSPO1	4.09e-06	191	58	6	MM17059
Coexpression	TSUNODA_CISPLATIN_RESISTANCE_DN	FBN1 FBN2 FN1 WNT5A	4.61e-06	50	58	4	M5014
Coexpression	NABA_ECM_GLYCOPROTEINS	FBN1 FBN2 VWF COMP FN1 RSPO1	4.74e-06	196	58	6	M3008
Coexpression	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	FLNA FBN1 FBN2 COMP FN1 WNT5A	5.33e-06	200	58	6	M5930
Coexpression	GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN	COL2A1 FLNA PELP1 INTS1 BTBD9 PREX2	5.33e-06	200	58	6	M6585
Coexpression	NABA_MATRISOME	COL2A1 FBN1 FBN2 VWF ANGPT1 COMP FN1 MUC17 WNT5A RSPO1	6.59e-05	1008	58	10	MM17056
Coexpression	NABA_MATRISOME	COL2A1 FBN1 FBN2 VWF ANGPT1 COMP FN1 MUC17 WNT5A RSPO1	7.64e-05	1026	58	10	M5889
Coexpression	GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS	FLNA FBN1 VWF ANGPT1 WNT5A PREX2 LIMS2	1.22e-04	505	58	7	M39167
Coexpression	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	FBN1 FBN2 COMP FN1 F2R ATP10D	1.26e-04	352	58	6	M17471
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000	FLNA RIMKLB FBN1 FBN2 FN1 WNT5A RNF19B RSPO1 CNN2 PLAC8 ATP10D RYR2	1.08e-06	797	57	12	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000
CoexpressionAtlas	dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000	FLNA RIMKLB FBN1 ANGPT1 FN1 WNT5A RNF19B RSPO1 CNN2 PLAC8 ATP10D RYR2	2.32e-06	858	57	12	gudmap_dev gonad_e11.5_F_GonMes_Sma_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	FLNA RIMKLB FBN1 FBN2 FN1 WNT5A RSPO1 DENND4C PLAC8 ATP10D RYR2	7.40e-06	797	57	11	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500	FLNA FBN1 FBN2 ANGPT1 WNT5A PLAC8	1.91e-05	207	57	6	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500
CoexpressionAtlas	dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_500	RIMKLB ANGPT1 WNT5A RNF19B RSPO1 CNN2 PLAC8 RYR2	2.03e-05	436	57	8	gudmap_dev gonad_e11.5_F_GonMes_Sma_500
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	FLNA FBN1 FN1 WNT5A CNN2	2.14e-05	125	57	5	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000	FLNA FBN1 FBN2 ANGPT1 FN1 WNT5A MROH2A FDX1 CNN2 PLAC8	3.53e-05	773	57	10	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000	FLNA RIMKLB FBN1 FBN2 ANGPT1 WNT5A RNF19B RSPO1 CNN2 PLAC8	6.49e-05	831	57	10	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500	RIMKLB FBN1 FBN2 WNT5A RSPO1 PLAC8 RYR2	7.39e-05	385	57	7	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000	FLNA FBN1 FBN2 ANGPT1 WNT5A PLAC8	7.60e-05	265	57	6	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500	FLNA RIMKLB FBN1 FBN2 ANGPT1 WNT5A PLAC8	1.23e-04	418	57	7	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500	FLNA RIMKLB FBN1 FBN2 ANGPT1 WNT5A PLAC8	1.33e-04	423	57	7	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	FLNA FBN1 FBN2 ANGPT1 WNT5A RSPO1 DENND4C PLAC8 RYR2	1.45e-04	740	57	9	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	KNTC1 FLNA FBN1 FBN2 ANGPT1 WNT5A FDX1 RNF19B CNN2	1.92e-04	768	57	9	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000	FLNA RIMKLB FBN1 FBN2 WNT5A RSPO1 DENND4C PLAC8 RYR2	2.21e-04	783	57	9	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1	COL2A1 ATRN RIMKLB FBN1 FBN2 VWF ANGPT1 FN1 WNT5A RNF19B RSPO1	2.34e-04	1166	57	11	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1
CoexpressionAtlas	Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05	COL2A1 VWF ANGPT1 FN1 RAI1	2.66e-04	213	57	5	PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlas	Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	COL2A1 VWF ANGPT1 FN1 RAI1	2.66e-04	213	57	5	PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	FLNA FBN1 ANGPT1 WNT5A MROH2A PLAC8	2.76e-04	336	57	6	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000	FLNA FBN1 FBN2 ANGPT1 WNT5A PLAC8	2.81e-04	337	57	6	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000
CoexpressionAtlas	JC_fibro_top-relative-expression-ranked_500	FBN1 ANGPT1 COMP FN1 WNT5A PLAC8 LIMS2	3.42e-04	494	57	7	JC_fibro_500
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000	FLNA FBN1 FBN2 ANGPT1 WNT5A PLAC8	3.65e-04	354	57	6	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500	FBN1 FBN2 WNT5A RSPO1 DENND4C RYR2	3.82e-04	357	57	6	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000	RIMKLB FBN1 ANGPT1 FN1 WNT5A RNF19B RSPO1 CNN2 PLAC8	4.02e-04	849	57	9	gudmap_dev gonad_e11.5_M_GonMes_Sma_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500	FBN1 FBN2 WNT5A RSPO1 PLAC8 RYR2	4.74e-04	372	57	6	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500
CoexpressionAtlas	kidney_e10.5_UretericTip_HoxB7_k-means-cluster#3_top-relative-expression-ranked_200	PREX2 PLAC8	5.42e-04	13	57	2	gudmap_kidney_e10.5_UretericTip_HoxB7_k3_200
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500	FBN1 FBN2 WNT5A PLAC8	6.38e-04	146	57	4	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500	FLNA FBN2 ANGPT1 PLAC8	6.72e-04	148	57	4	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k4_500
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FOXD2 FBN1 ANGPT1 COMP FN1 NALCN WNT5A RYR2	1.26e-10	181	60	8	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBN1 ANGPT1 COMP NALCN WNT5A MACF1 F2R	3.88e-09	175	60	7	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FLNA ANGPT1 COMP FN1 NALCN WNT5A F2R	4.90e-09	181	60	7	d7e04e0ca549eac6d9b1192b6578f9b54943d54f
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	FLNA FBN1 ANGPT1 FN1 WNT5A MACF1 PREX2	6.61e-09	189	60	7	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	PND07\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNA FBN1 FN1 WNT5A MACF1 CNN2 PLAC8	7.37e-09	192	60	7	8171a60df481195c39a7f740effcae8e4deb6ca7
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	FLNA ANGPT1 FN1 NALCN MACF1 F2R RYR2	7.64e-09	193	60	7	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	PND01-03-samps-Mesenchymal\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	FBN1 ANGPT1 FN1 WNT5A MACF1 CNN2 PREX2	7.91e-09	194	60	7	4f9bd0ded0dde1df885850714f29e73e992539a5
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	WDR91 ANGPT1 COMP FN1 NALCN WNT5A F2R	9.77e-09	200	60	7	251fd2923f108cd2086961d897244b392c32ad54
ToppCell	P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FBN1 ANGPT1 FN1 MACF1 F2R PREX2	1.68e-07	182	60	6	19c5e3a9d9b3728303b682102e276adfe93aa759
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	FBN1 ANGPT1 FN1 MACF1 CNN2 PREX2	2.10e-07	189	60	6	dc5164591dea45b420798b94dda211be03daa70c
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FBN1 VWF FN1 F2R PREX2 LIMS2	2.10e-07	189	60	6	b028466fcd36fdeceec752e55a24286a1cd62ae4
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	FBN1 ANGPT1 FN1 MACF1 CNN2 PREX2	2.17e-07	190	60	6	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Artery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FBN1 VWF FN1 F2R PREX2 LIMS2	2.17e-07	190	60	6	aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	FBN1 ANGPT1 FN1 MACF1 CNN2 PREX2	2.24e-07	191	60	6	e7c605b56934d1383237c1f946dbccef25d91368
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 ANGPT1 FN1 MACF1 F2R PREX2	2.24e-07	191	60	6	80484d39f34703a33b9bac09826b7a526e883cab
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 ANGPT1 FN1 MACF1 F2R PREX2	2.24e-07	191	60	6	5c4e4e9de14edfae072a2a2882220a31bebf51b2
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FBN1 ANGPT1 FN1 MACF1 PREX2 RYR2	2.38e-07	193	60	6	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	FBN1 ANGPT1 COMP FN1 NALCN RYR2	2.38e-07	193	60	6	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 ANGPT1 FN1 MACF1 CNN2 PREX2	2.53e-07	195	60	6	b616ee6f1d878935d293c8e0a8bbc5b4385301f0
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 ANGPT1 FN1 MACF1 CNN2 PREX2	2.53e-07	195	60	6	1c1135be421af98cd0077bec1ff2c4158d42aa21
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 ANGPT1 FN1 MACF1 CNN2 PREX2	2.53e-07	195	60	6	1f005ee1da66b539bd200aaa98f46edbbc7f12e4
ToppCell	PND07-Mesenchymal-Mesenchymal_structural\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 ANGPT1 FN1 MACF1 CNN2 PREX2	2.53e-07	195	60	6	2f9a274b26fc528a85f50933ec2f4db1dc9da0ca
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	FBN1 ANGPT1 FN1 MACF1 CNN2 PREX2	2.61e-07	196	60	6	54f4cf778f95a9ff662e5c7520916a25e605bf95
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 ANGPT1 FN1 WNT5A MACF1 PREX2	2.61e-07	196	60	6	2a885eed52f9b002c7995e11e450c7e8d7ae69e6
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 ANGPT1 FN1 WNT5A MACF1 PREX2	2.61e-07	196	60	6	14246f00c90741a5f8683f377e22e3a7c99661b9
ToppCell	PND07-Mesenchymal\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 ANGPT1 FN1 WNT5A MACF1 CNN2	2.61e-07	196	60	6	0050c7134473fbfd7b9f0ae8d6d337713e60b57d
ToppCell	MatrixFB\|World / shred on cell class and cell subclass (v4)	FBN1 ANGPT1 FN1 WNT5A MACF1 CNN2	2.69e-07	197	60	6	e325de44e32021a36fffb7b7e88167b46bb051c7
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 ANGPT1 FN1 MACF1 CNN2 PREX2	2.69e-07	197	60	6	06a0d7062dadda656decaf77dcef9a10b5f2698d
ToppCell	PND03-Mesenchymal\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNA FBN1 ANGPT1 FN1 WNT5A MACF1	2.69e-07	197	60	6	e3053ef8f604b6892c21c03e12612b49d3d30f23
ToppCell	PND01-Mesenchymal\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 ANGPT1 FN1 WNT5A MACF1 PREX2	2.69e-07	197	60	6	292b8cc3dafddf5d323fe4e3d3ea5ac61e6ce027
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 ANGPT1 FN1 MACF1 CNN2 PREX2	2.69e-07	197	60	6	d35c7a36135b5ed6a7bf2f934849678eba2a0177
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANGPT1 COMP FN1 NALCN F2R RYR2	2.69e-07	197	60	6	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	WDR91 ANGPT1 FN1 MACF1 F2R CNN2	2.77e-07	198	60	6	e0e47cf65774191981840b22905b2094b95abe0f
ToppCell	E18.5-Mesenchymal\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNA FBN1 ANGPT1 FN1 WNT5A MACF1	2.77e-07	198	60	6	a16aa41eab2e297e56de43c22c355df0f79315da
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FBN1 ANGPT1 FN1 MACF1 RSPO1 RYR2	2.77e-07	198	60	6	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLNA FBN1 FBN2 FN1 F2R CNN2	2.85e-07	199	60	6	36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FBN1 ANGPT1 FN1 MACF1 RSPO1 RYR2	2.85e-07	199	60	6	66a79732caf2f04c09b4d9832377aa01ca477677
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	VWF FN1 NPC1L1 BCR PREX2 LIMS2	2.85e-07	199	60	6	6a2943a23fdd2ec814662db7c21a0d6804a6cbbc
ToppCell	E16.5-Mesenchymal\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 ANGPT1 FN1 WNT5A MACF1 CNN2	2.85e-07	199	60	6	ebd9ca151434f5ca27a82d4f1815a1ea500c1989
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FBN1 ANGPT1 COMP FN1 WNT5A F2R	2.93e-07	200	60	6	b441b3771fb7d9ee7b7a104afc35e466aace2da2
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / Treatment groups by lineage, cell group, cell type	FBN1 VWF FN1 BCR PREX2 LIMS2	2.93e-07	200	60	6	b17eb1587ca86c3d40515128a00a8d8fd787fccf
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FBN1 VWF FN1 BCR PREX2 LIMS2	2.93e-07	200	60	6	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN2 VWF INTS1 XPO4 DENND4C	3.07e-06	167	60	5	774f3264318b002d0df5d06d41d645366038d0bf
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FBN1 VWF FN1 MACF1 PREX2	3.35e-06	170	60	5	7fa022471e14ac8a3bc147c793368a4d56a8e591
ToppCell	P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FBN1 ANGPT1 FN1 MACF1 CNN2	3.75e-06	174	60	5	3c47d069bd836599a8d40eae485c23d4d3487517
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|390C / Donor, Lineage, Cell class and subclass (all cells)	FBN2 COMP FN1 WNT5A RYR2	3.97e-06	176	60	5	852d3da0907fe87c0ef23d75a63ce07619cf0c54
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	FBN2 COMP FN1 WNT5A RYR2	3.97e-06	176	60	5	d2df1e435996c51213e88270af9f928e9e09a6f5
ToppCell	MatrixFB-Fibroblast-A\|MatrixFB / shred on cell class and cell subclass (v4)	FN1 FDX1 MACF1 CNN2 PREX2	4.43e-06	180	60	5	adc64ad6033af705dd7b9163a83e20ef5c59f6eb
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANGPT1 COMP FN1 NALCN F2R	4.55e-06	181	60	5	9c157de9d3403e092c907599f2a2c16db5b21131
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FBN1 ANGPT1 FN1 MACF1 F2R	4.55e-06	181	60	5	091e7975badd1ffa463a8ec87908be20781ecfd6
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANGPT1 COMP FN1 NALCN F2R	4.55e-06	181	60	5	eea943fdcbef0bbaa8578f3296923e874893b405
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FBN1 ANGPT1 FN1 PREX2 RYR2	4.55e-06	181	60	5	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLNA FN1 WSCD2 MACF1 LIMS2	4.55e-06	181	60	5	beb2771820956be8b190c0088ae3c4efdb53c897
ToppCell	P28-Mesenchymal\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FBN1 ANGPT1 FN1 MACF1 F2R	4.68e-06	182	60	5	69f9d44694fe4f55a971ae0ac5dc3e7448ee78f3
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	VWF F2R PREX2 RYR2 LIMS2	4.80e-06	183	60	5	dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	VWF F2R PREX2 RYR2 LIMS2	4.80e-06	183	60	5	4759560e5b4f4e5a00e5f933e3451a27c7c4aefe
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANGPT1 COMP FN1 NALCN F2R	4.80e-06	183	60	5	bc7dd6a40ec9c773d005c1a46f305d40cdd0a326
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANGPT1 FN1 MACF1 F2R PREX2	4.93e-06	184	60	5	924400f47e6b2cdf7b0d538df75857935cf0209b
ToppCell	P03\|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FLNA FBN1 FN1 MACF1 CNN2	5.06e-06	185	60	5	a07dbe1f76e40734a28826423a5cc64b8e56af5e
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FBN1 ANGPT1 FN1 MACF1 CNN2	5.06e-06	185	60	5	46460e74cc613df9043f5404e7342aa13cc34873
ToppCell	Endothelial-A-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	VWF F2R BCR PREX2 LIMS2	5.06e-06	185	60	5	dee0b7ba2f338f0979d2306aedf52ac35a36b60c
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FBN1 ANGPT1 FN1 MACF1 CNN2	5.20e-06	186	60	5	88e6246172d816806a498a5c1f38e699f2f5d7c2
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	FBN1 ANGPT1 FN1 MACF1 RYR2	5.33e-06	187	60	5	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	FBN1 ANGPT1 FN1 NALCN RYR2	5.33e-06	187	60	5	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	P15-Mesenchymal\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FBN1 ANGPT1 FN1 MACF1 CNN2	5.47e-06	188	60	5	f1ba0b661621a65c91432e62ba73531bdf18e7c1
ToppCell	Fibroblast-A\|World / shred on cell class and cell subclass (v4)	FBN1 ANGPT1 FN1 MACF1 CNN2	5.47e-06	188	60	5	6740bed5fb8f45b6eea17041894b804214c2a4ae
ToppCell	Mesenchymal-chondrocyte\|World / Lineage, Cell type, age group and donor	COL2A1 FBN1 FBN2 FN1 WSCD2	5.47e-06	188	60	5	7b1e3f8a941eaa68e89c562129a92314642eec66
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FBN1 VWF FN1 PREX2 LIMS2	5.62e-06	189	60	5	c45734970036e6d28d5e3fe7c9458fae38a3f624
ToppCell	COVID-19-kidney-AQP1+SLC14A1+EC\|kidney / Disease (COVID-19 only), tissue and cell type	FBN1 VWF FN1 PREX2 LIMS2	5.76e-06	190	60	5	1519f34d31fe0817184c5865a0bc9f0cb479b1a4
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNA FBN1 WNT5A MACF1 PREX2	5.76e-06	190	60	5	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 FN1 MACF1 F2R PREX2	5.91e-06	191	60	5	44a9a6768084dafc641ad455b65862bfd4cc0cb9
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FBN1 VWF FN1 PREX2 LIMS2	5.91e-06	191	60	5	b2c86cde341fe350143658c8a8a4a9edbce3f19b
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	FBN1 ANGPT1 FN1 MACF1 PREX2	5.91e-06	191	60	5	3379d145d34f89150f7b06d1340022cfc6b4a6ce
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANGPT1 FN1 MACF1 F2R PREX2	5.91e-06	191	60	5	beb5bb42bd53bce01339da9110d374901548793c
ToppCell	5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWF FN1 BCR PREX2 LIMS2	5.91e-06	191	60	5	adb2e3efcad02889d8229325080da5e7830fd3ae
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANGPT1 FN1 MACF1 F2R PREX2	5.91e-06	191	60	5	6609d85fd2577633dcc067507304a6f9e5865ca3
ToppCell	343B-Endothelial_cells-Endothelial-B_(Artery)\|343B / Donor, Lineage, Cell class and subclass (all cells)	VWF FN1 F2R PREX2 LIMS2	5.91e-06	191	60	5	27a532a35d9e8822014f581fd56c4ca62e39f8fe
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Artery\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FBN1 VWF FN1 PREX2 LIMS2	5.91e-06	191	60	5	4b3d5157344dbfbf4fab518611cd9fa37fac7bd9
ToppCell	343B-Endothelial_cells-Endothelial-B_(Artery)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	VWF FN1 F2R PREX2 LIMS2	5.91e-06	191	60	5	1dfcff08e01e6a695953334342bcfde04ba005ad
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FBN1 VWF F2R PREX2 LIMS2	6.06e-06	192	60	5	1ee4783051ec94ea94600f040edcb385fc4289f1
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 ANGPT1 FN1 MACF1 PREX2	6.06e-06	192	60	5	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FBN1 COMP FN1 NALCN WNT5A	6.06e-06	192	60	5	67e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FBN1 FN1 MACF1 CNN2 PREX2	6.06e-06	192	60	5	2802fae55683345ff94a1ecf73b6fbee4f17481e
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 ANGPT1 FN1 MACF1 PREX2	6.06e-06	192	60	5	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	15-Trachea-Endothelial-Endothelial\|Trachea / Age, Tissue, Lineage and Cell class	FBN1 VWF FN1 F2R LIMS2	6.22e-06	193	60	5	6ea0444fc3dc156997129387184e6418947f4b12
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 ANGPT1 FN1 MACF1 F2R	6.22e-06	193	60	5	4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0
ToppCell	Control-Fibroblasts-Vascular_smooth_muscle\|Control / group, cell type (main and fine annotations)	VWF ANGPT1 PREX2 RYR2 LIMS2	6.22e-06	193	60	5	60e44aac8be0430ad35e20eb98b1b700d76a0427
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 ANGPT1 FN1 MACF1 F2R	6.22e-06	193	60	5	ff8ceeb3cfd1bef7239df490c19d181091750833
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ANGPT1 FN1 MACF1 CNN2 PREX2	6.22e-06	193	60	5	8d05805295c5d3aa93aeb38be5fbefa81e1be1f0
ToppCell	15-Trachea-Endothelial\|Trachea / Age, Tissue, Lineage and Cell class	FBN1 VWF FN1 F2R LIMS2	6.22e-06	193	60	5	b1ebf8df2d55e2938e5a495ea68b80c4ac216dc0
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ANGPT1 FN1 MACF1 CNN2 PREX2	6.22e-06	193	60	5	1b2cc627b2aa002b442358bd1188d470e67ce7d9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FBN1 VWF FN1 PREX2 LIMS2	6.22e-06	193	60	5	0b328f725f6feba263783eaca60c142e80df90f3
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FBN1 COMP FN1 NALCN WNT5A	6.22e-06	193	60	5	5de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF F2R BCR PREX2 LIMS2	6.22e-06	193	60	5	7261c1ce30c796b61c6ec58e64a051baa24732ff
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FBN1 ANGPT1 FN1 MACF1 PREX2	6.38e-06	194	60	5	f15e81ff12525523c62d13105cf264ea72205e2e
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANGPT1 COMP FN1 NALCN F2R	6.38e-06	194	60	5	8fae8061b350336299aa81f378e07deadbd55123
ToppCell	368C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ANGPT1 FN1 MACF1 F2R CNN2	6.38e-06	194	60	5	d9eec28fa7b255c0ec023276dd955f1e276e7159
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANGPT1 COMP FN1 NALCN F2R	6.38e-06	194	60	5	4d7d24390fdb379f943ddcc70a63f23955e10163
ToppCell	368C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ANGPT1 FN1 MACF1 F2R CNN2	6.38e-06	194	60	5	e4d7e9709ce42d4610e44d3445927eefbcbb9eff
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FBN1 VWF FN1 PREX2 LIMS2	6.38e-06	194	60	5	b0c15e7e4bcf30856fb628dedd7ba82df33489f5
Computational	Adhesion molecules.	FBN1 FBN2 VWF COMP FN1	8.55e-05	141	35	5	MODULE_122
Computational	Actin cytoskeleton binding.	FLNA MACF1 CNN2	1.21e-04	30	35	3	MODULE_524
Computational	Genes in the cancer module 419.	FLNA MACF1 CNN2	1.77e-04	34	35	3	MODULE_419
Computational	Genes upregulated in subsets of cells of a given type within various tumors	FBN1 COMP FN1	5.58e-04	50	35	3	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1
Computational	ECM and collagens.	FBN1 VWF FN1 F2R CNN2	7.48e-04	225	35	5	MODULE_47
Drug	isodesmosine	COL2A1 FBN1 FBN2 FN1	1.57e-06	33	59	4	CID000013811
Drug	Rgd Peptide	COL2A1 FBN1 FBN2 VWF FN1 F2R RSPO1	2.76e-06	239	59	7	CID000104802
Drug	NC-4	COL2A1 VWF COMP FN1	5.11e-06	44	59	4	CID006420119
Drug	desmosine	COL2A1 FBN1 FBN2 FN1	1.08e-05	53	59	4	CID000025435
Disease	Disproportionate short stature	COL2A1 FLNA FBN1 COMP WNT5A	3.99e-07	77	57	5	C0878659
Disease	SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE	COL2A1 FN1	3.67e-06	2	57	2	184255
Disease	Spondylometaphyseal dysplasia - Sutcliffe type	COL2A1 FN1	3.67e-06	2	57	2	cv:C0432221
Disease	Spondylometaphyseal dysplasia, 'corner fracture' type	COL2A1 FN1	3.67e-06	2	57	2	C0432221
Disease	osteochondrodysplasia (is_implicated_in)	COL2A1 FLNA COMP	6.48e-06	19	57	3	DOID:2256 (is_implicated_in)
Disease	monocyte count	WDR91 ATRN TMEM156 ANGPT1 FN1 GCKR F2R CNN2 ELL PREX2 PLAC8 RAI1	6.67e-06	1320	57	12	EFO_0005091
Disease	connective tissue disease (implicated_via_orthology)	FBN1 FBN2	1.10e-05	3	57	2	DOID:65 (implicated_via_orthology)
Disease	scoliosis (is_implicated_in)	FBN1 FBN2	2.19e-05	4	57	2	DOID:0060249 (is_implicated_in)
Disease	reticulocyte measurement	ATRN FLNA RIMKLB VWF ANGPT1 GATAD2A AK5 LYG2 GCKR ELL	3.02e-05	1053	57	10	EFO_0010700
Disease	Spondylometaphyseal dysplasia	COL2A1 FN1	7.65e-05	7	57	2	cv:C4759767
Disease	Type II Collagenopathies	COL2A1 FN1	7.65e-05	7	57	2	cv:CN043672
Disease	ferritin measurement	FN1 DHX38 GCKR ELL	8.42e-05	119	57	4	EFO_0004459
Disease	LEUKEMIA, ACUTE LYMPHOBLASTIC	NUP214 BCR	1.02e-04	8	57	2	613065
Disease	mesangial proliferative glomerulonephritis (biomarker_via_orthology)	FBN1 VWF	1.02e-04	8	57	2	DOID:4783 (biomarker_via_orthology)
Disease	level of Triacylglycerol (49:2) in blood serum	GATAD2A GCKR	1.02e-04	8	57	2	OBA_2045162
Disease	Acute lymphoid leukemia	NUP214 BCR	1.02e-04	8	57	2	cv:C0023449
Disease	Liver Cirrhosis, Experimental	ATRN FLNA FBN1 VWF F2R BCR PLAC8 ATP10D	1.15e-04	774	57	8	C0023893
Disease	mitral valve prolapse (is_implicated_in)	FLNA FBN1	1.31e-04	9	57	2	DOID:988 (is_implicated_in)
Disease	Familial thoracic aortic aneurysm and aortic dissection	FLNA FBN1 FBN2	1.49e-04	53	57	3	C4707243
Disease	ascending aortic diameter	FBN1 FBN2 ANGPT1 RYR2	1.58e-04	140	57	4	EFO_0021787
Disease	level of Triacylglycerol (51:3) in blood serum	GATAD2A GCKR	1.63e-04	10	57	2	OBA_2045163
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	GATAD2A NPC1L1 MACF1 GCKR	1.76e-04	144	57	4	EFO_0004611, EFO_0020943
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	GATAD2A DHX38 NPC1L1 MACF1 GCKR	2.48e-04	291	57	5	EFO_0008317, EFO_0020946
Disease	diastolic blood pressure, systolic blood pressure	FBN1 ANGPT1 GATAD2A PELP1 RSPO1 ELL RYR2	2.98e-04	670	57	7	EFO_0006335, EFO_0006336
Disease	eating disorder, bipolar disorder	NALCN RYR2	3.29e-04	14	57	2	EFO_0005203, MONDO_0004985
Disease	Spondyloepiphyseal Dysplasia	COL2A1 FLNA	4.32e-04	16	57	2	C0038015
Disease	Spondyloepiphyseal Dysplasia Tarda, X-Linked	COL2A1 FLNA	4.32e-04	16	57	2	C3541456
Disease	Schwartz-Jampel Syndrome, Type 1	COL2A1 FLNA	4.32e-04	16	57	2	C4551479
Disease	Schwartz-Jampel Syndrome	COL2A1 FLNA	4.32e-04	16	57	2	C0036391
Disease	Melnick-Needles Syndrome	COL2A1 FLNA	4.32e-04	16	57	2	C0025237
Disease	Van Buchem disease	COL2A1 FLNA	4.89e-04	17	57	2	C0432272
Disease	HMG CoA reductase inhibitor use measurement	DHX38 NPC1L1 GCKR DENND4C	4.94e-04	189	57	4	EFO_0009932
Disease	Osteochondrodysplasias	COL2A1 FLNA	6.14e-04	19	57	2	C0029422
Disease	Dyschondroplasias	COL2A1 FLNA	6.14e-04	19	57	2	C0013366
Disease	Multiple Epiphyseal Dysplasia	COL2A1 FLNA	6.81e-04	20	57	2	C0026760
Disease	Idiopathic Pulmonary Fibrosis	ABCA3 WNT5A	7.52e-04	21	57	2	C1800706
Disease	reticulocyte count	ATRN RIMKLB VWF ANGPT1 GATAD2A LYG2 GCKR F2R	8.54e-04	1045	57	8	EFO_0007986
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	GATAD2A DHX38 NPC1L1 GCKR	9.47e-04	225	57	4	EFO_0008317, EFO_0010351
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	DHX38 NPC1L1 MACF1 GCKR	9.47e-04	225	57	4	EFO_0008317, EFO_0020947
Disease	neuroimaging measurement	COL2A1 FBN2 ANGPT1 GATAD2A MACF1 BCR DENND4C RAI1	9.89e-04	1069	57	8	EFO_0004346
Disease	Malignant neoplasm of breast	FLNA ABCA3 VWF FN1 EHMT1 MACF1 DHX32 NUP214	1.02e-03	1074	57	8	C0006142
Disease	ceramide measurement	GATAD2A GCKR CNN2 ATP10D	1.11e-03	235	57	4	EFO_0010222
Disease	mean corpuscular hemoglobin concentration	KNTC1 ANGPT1 GATAD2A MACF1 DHX32 GCKR BTBD9 ELL	1.22e-03	1105	57	8	EFO_0004528
Disease	aortic measurement	FBN1 ANGPT1 ELL RYR2	1.42e-03	251	57	4	EFO_0020865
Disease	triacylglycerol 56:7 measurement	GATAD2A GCKR	1.44e-03	29	57	2	EFO_0010434
Disease	body surface area	KNTC1 FBN1 FBN2 MACF1 GCKR ZNF844	1.48e-03	643	57	6	EFO_0022196
Disease	Epileptic encephalopathy	FLNA NUP214	1.54e-03	30	57	2	C0543888
Disease	triacylglycerol 50:4 measurement	GATAD2A GCKR	1.54e-03	30	57	2	EFO_0010411
Disease	facial hair thickness measurement	MACF1 RSPO1	1.75e-03	32	57	2	EFO_0007823
Disease	uridine measurement	NALCN PLAC8	1.75e-03	32	57	2	EFO_0010546
Disease	lymphocyte count	COL2A1 FBN1 FN1 GCKR BCR CNN2 PREX2 RAI1 LIMS2	1.86e-03	1464	57	9	EFO_0004587
Disease	Inflammation	COL2A1 ANGPT1 F2R	1.92e-03	127	57	3	C0021368

Protein segments in the cluster

Peptide	Gene	Start	Entry
NMSAKDGTCTLQDCM	ELL	251	P55199
MNTDLAAGKMASAAC	CREB3L3	1	Q68CJ9
AMEMAEKCCQANAQF	BCR	601	P11274
GCQICLTKSMDNMTV	FDX1	151	P10109
FLKNTVMECDACGMQ	COMP	61	P49747
VMECDACGMQQSVRT	COMP	66	P49747
CSCLLSNVAMAMGAQ	ABCA3	406	Q99758
DNDNCMCKCALMLTG	ANGPT1	431	Q15389
STMNKEQQMCETCPE	DHX32	721	Q7L7V1
LNTQSKDACGMLMST	ATP10D	946	Q9P241
CTLDAMKVFCNMETG	COL2A1	1306	P02458
ITNKACMMDTTGMSC	R3HCC1L	371	Q7Z5L2
VAVDMMCSSCQEAGA	RAI1	1851	Q7Z5J4
EKSGAIMCENCMTTN	GATAD2A	431	Q86YP4
MTGSNMSDALANAVC	LIMS2	1	Q7Z4I7
VCMNCNTHGSEDMDV	INTS1	391	Q8N201
QLVICMDCSADTMTN	AK5	481	Q9Y6K8
SSECMWCSNMKQCVD	ATRN	946	O75882
KSGCMQTHPSMNLDC	LINC00474	36	Q9P2X8
SCDNLTLSACMMSSE	NUP214	101	P35658
RQCQMDDCGILMKAS	KNTC1	1166	P50748
CEQSALEGMKACMTY	PELP1	191	Q8IZL8
KDMLIACNQTAEMSC	MACF1	2796	Q9UPN3
GQLMASKMDTCSSNL	F2R	401	P25116
FVAGQMDCCMNNTAV	GCKR	186	Q14397
SLNCLKNCMSITMGS	NPC1L1	986	Q9UHC9
EDVQAMSNCCQDMTS	COG6	106	Q9Y2V7
MSNCCQDMTSRLQAA	COG6	111	Q9Y2V7
SEAKMSCMDNKDGSC	FLNA	1396	P21333
DRQGENGQMMSCTCL	FN1	2356	P02751
EDMDECSIRNMCLNG	FBN1	571	P35555
MCLNGMCINEDGSFK	FBN1	581	P35555
QNCAMEVLMSSCSQC	DENND4C	1481	Q5VZ89
MKTSGATCDANSVMN	LYG2	46	Q86SG7
CTTTNMCLNGMCINE	FBN2	621	P35556
MCLNGMCINEDGSFK	FBN2	626	P35556
CMIMNGGCDTQCTNS	FBN2	1246	P35556
NGFKASQDQTMCMDV	FBN2	1921	P35556
CCMFMDRNAQEVLSS	BTBD9	161	Q96Q07
AEMCCTALNSEHMNT	RYR2	3261	Q92736
DDCSSSNCMCGQLSM	EHMT1	1066	Q9H9B1
INDICSDMMCFNTTG	MUC17	4286	Q685J3
QDPCSNAAQACMATM	MROH2A	1526	A6NES4
MTLGSCCCEIMSSES	FOXD2	1	O60548
KMNDGSCNHMTCAVC	RNF19B	296	Q6ZMZ0
AQESMCTEDMRKSSC	TDRD6	1931	O60522
CDQGGECDLQDQSMM	NDUFS1	131	P28331
ANGTMECSSPAQCEM	RSPO1	136	Q2MKA7
KCVCDSQMSVSEMSC	SYT14P1	21	Q58G82
GTDKCDNSSMSLQMG	CNN2	236	Q99439
CQGMSKEDDMNHCVK	C10orf82	26	Q8WW14
MCSSCLVCESKGNMD	TMEM156	96	Q8N614
GSLDNSEQKCIAMCM	TIMM13	56	Q9Y5L4
ELGMTSMSSEVCQLC	XPO4	1011	Q9C0E2
CHNNIMKQTMVDSSC	VWF	1046	P04275
MGCCQDKDFEMSDEQ	TEX54	1	A0A1B0GVG6
SKMLIVSCDMGCSSE	DHX38	956	Q92620
GSNITDTCTEMLMCG	PREX2	236	Q70Z35
NKTSEGMDGCELMCC	WNT5A	326	P41221
TMLRCSTDGRMQSNC	RIMKLB	216	Q9ULI2
CMKGLTLESNCMNLN	ZNF844	521	Q08AG5
KMFCQCDSCGMSFNT	ZNF33A	136	Q06730
ADMNECCLCGTSVAM	PLAC8	56	Q9NZF1
AAMLNMSVDKCVDFC	WSCD2	251	Q2TBF2
TAMDCGTCLTASMDG	WDR91	721	A4D1P6
HCNDSKLSMCTMDEV	USP44	651	Q9H0E7
CKMNPMTDAASCGSE	NALCN	1701	Q8IZF0